Fitbit announced its new range of fitness-focused smartwatches near the end of August, and we have some good news regarding the more expensive, and thus fuller-featured model, the Sense. Fitbit has announced that the Sense’s electrodermal activity (EDA) sensor will soon gain the ability to assess your heart rhythm for atrial fibrillation (AFib) using the brand’s newly approved ECG app.
The feature works by opening up the ECG app on your Fitbit Sense and holding your fingers on the corners of the stainless steel ring around the watch for 30 seconds. Once your heart rhythm has been assessed, the ECG app will show if your heart rhythm is normal, shows signs of AFib, or if the reading is inconclusive and needs to be re-done.
How does it work?
Your heart generates electrical activity that is responsible for the pumping action of the heart. Enter the two electrical sensors on the Fitbit Sense, one on the top and another on the bottom. By making contact with one sensor on your wrist and the other with your opposite hand, you create a closed electrical circuit, which lets the ECG app record the electrical signals from your heart and analyzes them for AFib.
The ECG app will become available to download for the Fitbit Sense during October in the following countries:
- United States
- United Kingdom
- Czech Republic
- Hong Kong
Already available to pre-order, the new Fitbit Sense will begin shipping from September 25th and we have a unit coming in for review.
Pre-order Here: Fitbit
OPPO Find X2 Neo review: A smooth operator
Having trouble with your Galaxy Buds in the sun? You aren’t the only one
Good news sports fans! The One UI 2.5 update is coming to Samsung’s Galaxy S9 and Note 9 (and a whole lot more)